SEC Form 4 · accession 0001179110-18-013777
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeffrey Ryan Stewart
Officer — SVP, US Commercial Operations
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par valueF1 | Dec 10, 2018 | A | 11,595 | $0.00 | A | 41,073 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities represent restricted stock units granted under the AbbVie 2013 Incentive Stock Program. They vest in annual increments of 21,514 on 12/09/2016, 21,513 on 12/09/2017, and 21,513 on 12/09/2018, and include the right to have stock withheld for tax purposes.